HUP0101350A2 - Generalizált szorongásos rendellenesség kezelése paroxetinnel - Google Patents

Generalizált szorongásos rendellenesség kezelése paroxetinnel

Info

Publication number
HUP0101350A2
HUP0101350A2 HU0101350A HUP0101350A HUP0101350A2 HU P0101350 A2 HUP0101350 A2 HU P0101350A2 HU 0101350 A HU0101350 A HU 0101350A HU P0101350 A HUP0101350 A HU P0101350A HU P0101350 A2 HUP0101350 A2 HU P0101350A2
Authority
HU
Hungary
Prior art keywords
paroxetine
treatment
anxiety disorder
generalized anxiety
generalized
Prior art date
Application number
HU0101350A
Other languages
English (en)
Inventor
Rocco Zaninelli
Original Assignee
Smithkline Beecham Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp. filed Critical Smithkline Beecham Corp.
Publication of HUP0101350A2 publication Critical patent/HUP0101350A2/hu
Publication of HUP0101350A3 publication Critical patent/HUP0101350A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A találmány a paroxetinnek vagy gyógyászatilag elfogadható sóinak vagyszolvátjainak a generalizált szorongásos rendellenesség kezeléséretörténő alkalmazására vonatkozik. Ó
HU0101350A 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine HUP0101350A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment

Publications (2)

Publication Number Publication Date
HUP0101350A2 true HUP0101350A2 (hu) 2002-05-29
HUP0101350A3 HUP0101350A3 (en) 2002-06-28

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101350A HUP0101350A3 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Country Status (20)

Country Link
EP (1) EP1073437A4 (hu)
JP (1) JP2002512189A (hu)
KR (1) KR20010034817A (hu)
CN (1) CN1298301A (hu)
AP (1) AP2000001959A0 (hu)
AU (1) AU3864899A (hu)
BG (1) BG104939A (hu)
BR (1) BR9909791A (hu)
CA (1) CA2328896A1 (hu)
CZ (1) CZ20003885A3 (hu)
EA (1) EA200001088A1 (hu)
GB (1) GB9808479D0 (hu)
HU (1) HUP0101350A3 (hu)
ID (1) ID27546A (hu)
IL (1) IL139167A0 (hu)
NO (1) NO20005286L (hu)
PL (1) PL343494A1 (hu)
SK (1) SK15672000A3 (hu)
TR (1) TR200003082T2 (hu)
WO (1) WO1999053919A1 (hu)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
CZ20003885A3 (cs) 2001-09-12
EP1073437A4 (en) 2003-04-16
NO20005286D0 (no) 2000-10-20
GB9808479D0 (en) 1998-06-17
JP2002512189A (ja) 2002-04-23
ID27546A (id) 2001-04-12
TR200003082T2 (tr) 2001-01-22
KR20010034817A (ko) 2001-04-25
IL139167A0 (en) 2001-11-25
EP1073437A1 (en) 2001-02-07
BG104939A (bg) 2001-09-28
AU3864899A (en) 1999-11-08
PL343494A1 (en) 2001-08-27
HUP0101350A3 (en) 2002-06-28
EA200001088A1 (ru) 2001-04-23
CA2328896A1 (en) 1999-10-28
AP2000001959A0 (en) 2000-12-31
BR9909791A (pt) 2000-12-26
CN1298301A (zh) 2001-06-06
WO1999053919A1 (en) 1999-10-28
NO20005286L (no) 2000-12-20
SK15672000A3 (sk) 2001-04-09

Similar Documents

Publication Publication Date Title
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ATE302775T1 (de) Carbolinderivate
PT1333887E (pt) Metodo de tratamento de desordens musculares
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
DE60216233D1 (en) Carbolinderivate
ATE425253T1 (de) Tribonektine
DE60121461D1 (de) Kondensierte pyridoindolderivate
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
DE60127537D1 (de) VERWENDUNG VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLOÄ1,5-bÜPYRIDAZINE ZUR BEHANDLUNG VON NICHTULZERATIVER DYSPEPSIE
BR0314844A (pt) Novo composto
BR0314843A (pt) Novo composto
DE69935873D1 (de) 2-Methyl-thieno-benzodiazepin Formulierung
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
HUP0101350A2 (hu) Generalizált szorongásos rendellenesség kezelése paroxetinnel
TR200100240T2 (tr) Anksiyete bozukluklarının tedavisi
AR027349A1 (es) Derivados de amidas heterociclicas
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
CO5021190A1 (es) Agentes terapeuticos
FR2802101B1 (fr) Association de cymemazine et d'un neuroleptique atypique
BR0206918A (pt) Uso de iloperidona
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.